241 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
Clinical Trials of SGLT2 ... ASCVD; signal for SGLT2i ... risk; signal for SGLT2i ... HF outcomes in HFrEF ... HF outcomes in HFrEF
Heart Failure with Reduced Ejection Fraction (HFrEF) - Guideline Directed Medical Therapy - Initiation Strategies

 •
Ejection Fraction (HFrEF ... Beta-Blocker → MRA → SGLT ... Beta-Blocker + SGLT ... #Failure #CHF #HFrEF ... #Guideline #management
Heart Failure with Reduced Ejection Fraction (HFrEF) - Guideline Directed Medical Therapy
 • Beta-blocker
 • ACE,
Ejection Fraction (HFrEF ... ARNI • MRA • SGLT ... #Failure #CHF #HFrEF ... #Guideline #management
Guidelines Directed medical therapy for Heart Failure 

Satyendra Dhar, MD, @DharSaty

#HFrEF #GDMT #sodium-glucosecotransporter-2inhibitors #SGLT2i #reninangiotensinaldosteronesysteminhibitors
@DharSaty #HFrEF ... sodium-glucosecotransporter-2inhibitors #SGLT2i
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Stable Angina, HFpEF ... , HFrEF, AFib, TAA ... pharmacology #table #management
"Suggested management of chronic heart failure. Adapted from the 2016 European Society of Cardiology guidelines"-McMaster Textbook
"Suggested management ... Pharmacotherapy of HFrEF ... #CHF #Management ... #HFrEF #Cardiology
Treatment options for patients with Chronic Symptomatic Systolic Heart Failure

#sCHF #CongestiveHeartFailure #Systolic #HFrEF #Algorithm #Management #Cardiology
CongestiveHeartFailure #Systolic #HFrEF ... #Algorithm #Management
Algorithm for screening/diagnosis and treatment/follow‐up of iron deficiency in patients with chronic heart failure. Hb, haemoglobin;
, haemoglobin; HFrEF ... Iron #Deficiency #Management ... #Diagnosis #HFrEF
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
heart failure; HFpEF ... ejection fraction; HFrEF ... ACCAHA #Algorithm #Management
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
drugs Other than SGLT2i ... receptor agonist SGLT2i ... #CKD #Diabetes Management ... in CKD #management